Polymorphisms of cytochrome p450 and adverse events of tamoxifen therapy

被引:0
|
作者
Ignatova, A. [1 ]
Zacharenkova, J. [2 ]
Dudina, I. [2 ]
Savelyeva, M. [3 ]
机构
[1] Sechenov Univ, Minist Hlth Russian Federat, IM Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Sechenov Univ, Moscow, Russia
[3] Russian Med Acad Postgrad Educ, Moscow, Russia
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
EACPT-1175
引用
收藏
页码:S20 / S21
页数:2
相关论文
共 50 条
  • [1] Effects of cytochrome P450 polymorphisms on tamoxifen metabolism.
    Sawyer, MB
    Damaraju, S
    Pituskin, E
    Carter, SJ
    Dufour, J
    Carandang, D
    Hanson, J
    Mackey, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 148S - 148S
  • [2] Cytochrome P450 enzyme polymorphisms and adverse drug reactions
    Pirmohamed, M
    Park, BK
    [J]. TOXICOLOGY, 2003, 192 (01) : 23 - 32
  • [3] Cytochrome P450 polymorphisms and response to antipsychotic therapy
    Scordo, MG
    Spina, E
    [J]. PHARMACOGENOMICS, 2002, 3 (02) : 201 - 218
  • [4] Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy
    Winoto, J.
    Song, H.
    Hines, C.
    Nagaraja, H.
    Rovin, B. H.
    [J]. CLINICAL NEPHROLOGY, 2011, 75 (05) : 451 - 457
  • [5] Polymorphisms of cytochrome P450 and xenobiotic toxicity
    Ingelman-Sundberg, M
    [J]. TOXICOLOGY, 2001, 164 (1-3) : 33 - 33
  • [6] P450 polymorphisms and adverse drug reactions
    Pirmohamed, M
    [J]. TOXICOLOGY, 2003, 192 (01) : 55 - 56
  • [7] Cytochrome P450 Polymorphisms in Geriatric PatientsImpact on Adverse Drug Reactions — A Pilot Study
    Tobias Egger
    Harald Dormann
    Gabi Ahne
    Andreas Pahl
    Ulrich Runge
    Tanya Azaz-Livshits
    Antje Neubert
    Manfred Criegee-Rieck
    Karl G. Gassmann
    Kay Brune
    [J]. Drugs & Aging, 2005, 22 : 265 - 272
  • [8] Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes
    Notley, LM
    de Wolf, CJF
    Wunsch, RM
    Gillam, EMJ
    [J]. TOXICOLOGY, 2001, 164 (1-3) : 139 - 139
  • [9] Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes
    Notley, LM
    de Wolf, CJF
    Wunsch, RM
    Lancaster, RG
    Gillam, EMJ
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (05) : 614 - 622
  • [10] Cytochrome P450 polymorphisms and the individualization of drug treatment
    Daly, AK
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 21 - 21